Immunogenicity and safety of recombinant tetravalent dengue vaccine (CYD-TDV) in individuals aged 2-45 y: Phase II randomized controlled trial in Singapore (Q36631286)
Jump to navigation
Jump to search
scientific article published on 16 August 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Immunogenicity and safety of recombinant tetravalent dengue vaccine (CYD-TDV) in individuals aged 2-45 y: Phase II randomized controlled trial in Singapore |
scientific article published on 16 August 2012 |
Statements
1 reference
Immunogenicity and safety of recombinant tetravalent dengue vaccine (CYD-TDV) in individuals aged 2-45 y: Phase II randomized controlled trial in Singapore (English)
1 reference
Yee Sin Leo
1 reference
Anneliese Wilder-Smith
1 reference
Sophia Archuleta
1 reference
Chia-Yin Chong
1 reference
Hoe Nam Leong
1 reference
Chian Yong Low
1 reference
May-Lin Helen Oh
1 reference
Alain Bouckenooghe
1 reference
T Anh Wartel
1 reference
Denis Crevat
1 reference
1 reference